These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22813447)

  • 61. DNA content analysis of uveal melanoma.
    McMillan J; Char DH; McLean IW; Gamel JW
    Arch Ophthalmol; 1989 Sep; 107(9):1278. PubMed ID: 2783056
    [No Abstract]   [Full Text] [Related]  

  • 62. Genomic typing of uveal melanoma.
    Damato B; Coupland SE
    Arch Ophthalmol; 2009 Jan; 127(1):113-4; author reply 114-5. PubMed ID: 19139354
    [No Abstract]   [Full Text] [Related]  

  • 63. Author reply: To PMID 22521086.
    Harbour JW; Augsburger JJ; Char DH
    Ophthalmology; 2013 Jul; 120(7):e51. PubMed ID: 23823529
    [No Abstract]   [Full Text] [Related]  

  • 64. The mathematics of melanoma volume.
    O'Rourke J
    Arch Ophthalmol; 1986 Jul; 104(7):973-5. PubMed ID: 3729789
    [No Abstract]   [Full Text] [Related]  

  • 65. Variability of High-risk Uveal Melanoma Survival Estimates Across Studies Based on 15-Gene Expression Profiling.
    Cook RW; Alsina KM
    JAMA Ophthalmol; 2023 Feb; 141(2):212. PubMed ID: 36547988
    [No Abstract]   [Full Text] [Related]  

  • 66. Variability of High-risk Uveal Melanoma Survival Estimates Across Studies Based on 15-Gene Expression Profiling-In Reply.
    Singh AD; Binkley EM; Bena JF
    JAMA Ophthalmol; 2023 Feb; 141(2):212-213. PubMed ID: 36547941
    [No Abstract]   [Full Text] [Related]  

  • 67. Echographic and histologic tumor height measurements in uveal melanoma.
    Coleman DJ
    Am J Ophthalmol; 1986 Jan; 101(1):124-6. PubMed ID: 3942169
    [No Abstract]   [Full Text] [Related]  

  • 68. Echographic and histologic tumor height measurements in uveal melanoma.
    Seddon JM; Gragoudas E; Albert D; Hsieh CC; Polivogianis L; Egan K
    Am J Ophthalmol; 1986 Jan; 101(1):126-8. PubMed ID: 3942170
    [No Abstract]   [Full Text] [Related]  

  • 69. Lymphocyte subpopulations in uveal malignant melanoma.
    Kaplan HJ
    Am J Ophthalmol; 1986 Apr; 101(4):483-5. PubMed ID: 3963109
    [No Abstract]   [Full Text] [Related]  

  • 70. Uveal melanoma: doubling time and mitotic index.
    Juster RP; Char DH
    Arch Ophthalmol; 1986 Feb; 104(2):174-5. PubMed ID: 3947284
    [No Abstract]   [Full Text] [Related]  

  • 71. Prognosis in ocular melanoma.
    Hungerford J
    Br J Ophthalmol; 1989 Sep; 73(9):689-90. PubMed ID: 2679874
    [No Abstract]   [Full Text] [Related]  

  • 72. Authors’ reply.
    Lake SL; Kalirai H; Dodson AR; Coupland SE; Lloyd BH; Damato BE; Taktak AF
    Am J Pathol; 2013 Aug; 183(2):638-40. PubMed ID: 24049776
    [No Abstract]   [Full Text] [Related]  

  • 73. Butein and its emerging anti-proliferative and pro-apoptotic effects in systemic malignancies.
    Kapoor S
    Curr Eye Res; 2013 Jul; 38(7):810. PubMed ID: 23621171
    [No Abstract]   [Full Text] [Related]  

  • 74. Uveal melanoma in children and teenagers.
    Shields CL; Kaliki S; Arepalli S; Atalay HT; Manjandavida FP; Pieretti G; Shields JA
    Saudi J Ophthalmol; 2013 Jul; 27(3):197-201. PubMed ID: 24227986
    [TBL] [Abstract][Full Text] [Related]  

  • 75. American joint committee on cancer staging of uveal melanoma.
    Mellen PL; Morton SJ; Shields CL
    Oman J Ophthalmol; 2013 May; 6(2):116-8. PubMed ID: 24082672
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Uveal melanoma trapped in the temple of doom.
    Shields CL; Ganguly A; O'Brien J; Sato T; Shields JA
    Am J Ophthalmol; 2012 Aug; 154(2):219-21. PubMed ID: 22813447
    [No Abstract]   [Full Text] [Related]  

  • 77. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens.
    Shields CL; Ganguly A; Bianciotto CG; Turaka K; Tavallali A; Shields JA
    Ophthalmology; 2011 Feb; 118(2):396-401. PubMed ID: 20869116
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genomic investigations of posterior uveal melanoma.
    Hovland PG; Trempe C
    Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
    Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
    Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Uveal melanoma: prognostication.
    Turell ME; Tubbs RR; Biscotti CV; Singh AD
    Monogr Clin Cytol; 2012; 21():55-60. PubMed ID: 22024584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.